Javier San Martin

Chief Tech/Sci/R&D Officer at ATHIRA PHARMA, INC.

Net worth: 6 M $ as of 2024-03-30

58 year

Health Technology

Consumer Services

Javier San Martin active positions

Companies	Position	Start	End
ATHIRA PHARMA, INC.	Chief Tech/Sci/R&D Officer	2024-04-14	-

Companies	Position	Start	End
ARROWHEAD PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2019-11-17	2024-01-31
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	2013-11-30	2019-10-31
AMGEN INC.	Corporate Officer/Principal	-	-
ELI LILLY AND COMPANY	Corporate Officer/Principal	-	-
ALDER BIOPHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-

University of Buenos Aires School of Medicine

Doctorate Degree

International

United States	7
Argentina	2

Operational

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Sectoral

Health Technology	7
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	5
AMGEN INC.	Health Technology
ELI LILLY AND COMPANY	Health Technology
ARROWHEAD PHARMACEUTICALS, INC.	Health Technology
ULTRAGENYX PHARMACEUTICAL INC.	Health Technology
ATHIRA PHARMA, INC.	Health Technology

Private companies	1
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.	Health Technology

Private companies

Health Technology